A special Session showcasing high impact innovations and its practitioners. The session speakers deliberate on how leaders across industries have handled disruption and share their strategies and innovation practices.
A special session exploring the emerging business technologies and resulting challenges and opportunities with eminent speakers from India and Israel – Harsh Pati Singhania, President AIMA & Vice Chairman & MD, JK Paper Ltd; Ilanit Kabessa, Corporate Venturing & Innovation Advisor, AgriFood Industries; David Schwartz, VP Tech Venturing & Innovation, Pepsico; Neil Ackerman, Global Supply Chain, Digital Executive, Johnson & Johnson; Pramod Bhasin, Founder, Genpact and Chairman, Clix Capital; Rekha Sethi, Director General, AIMA ; Pranjal Sharma, Economic Analyst, Advisor & Writer & Author, India Automated; Natasha Zangin, Counsellor, Head of Economic & Commercial Mission and Dan Fishel, VP, Business Development, Our Crowd
A special session on 'Impact of US Elections on Indo - US Relations'. The session analyses the impact of US election results on the US and the world. A joint programmes with Covington & Burling LLP, a prominent US Public Policy practice group.
Shereen Bhan, Managing Editor, CNBC-TV18; Amitabh Chaudhry, Managing Director & CEO, Axis Bank; Chandra Shekhar Ghosh, Managing Director & CEO, Bandhan Bank; Hemant Kanoria, Chairman, Srei Infrastructure Finance Limited discuss the need of reformation for Indian Banking system. A wealth of fresh capital is urgently required by banks, NBFCs, HFCs and insurers to ensure confidence in the system, once moratorium and loan and interest repayment is called off.
Ruchi Bhatia, Deputy Chief of Delhi Bureau, ET Now; Vani Kola, Managing Director, Kalaari Capital; Falguni Nayar, Founder and CEO, Nykaa.com; Yashish Dahiya, Co-founder & Group CEO, Policybazaar.com; Peyush Bansal, Founder & Chief Executive Officer, Lenskart.com deliberate on ways Indian startups have to shift focus from buying users to eking out profits and repaying investors.
Sanjay Kirloskar, Chairman and Managing Director, Kirloskar Brothers Ltd; Arvind Panagariya, Former Vice Chairman, NITI Aayog and Professor of Economics and the Jagdish Bhagwati Professor of Indian Political Economy at Columbia University; C K Ranganathan, Chairman and Managing Director, CavinKare Pvt. Ltd deliberate upon the policies taken by the Government to mend the economy through relief to the producers, especially MSMEs and farmers.
Sunil Kant Munjal, Chairman, Hero Enterprise; Bhavish Aggarwal, Co-Founder & CEO, Ola; Ritesh Agarwal, Founder and Group CEO, OYO Hotels & Homes contemplate on ways hospitality and transportation need to reimagine their business and operating models, to serve and survive; as consumer mindset leans towards maintaining social distance in crowd gatherings.
Pranjal Sharma, Economic Analyst, Advisor and Writer & Author-India Automated; Nirupama Rao, Former Foreign Secretary and Ambassador of India to China, USA & Sri Lanka; Claude Smadja, Chairman, Smadja & Smadja Strategic Advisory Inc and Harry Broadman, Partner & Practice Chair, Berkeley Research Group LLC; Johns Hopkins University Faculty; Author, Africa's Silk Road: China and Indias New Economic Frontier discuss how India has to find ways to solve its security and economic conundrum as it coexists with its neighbour China.
Nayantara Rai, Chief of Delhi Bureau, ET-Now; Rajnish Kumar, Chairman, State Bank of India; Sanjiv Mehta, Chairman & Managing Director, Hindustan Unilever Limited and Sanjiv Bajaj, Chairman and Managing Director, Bajaj Finserv Ltd discuss that while India's economy is down with the flu, it has presented an opportunity to renew its economy by moving forward with radical ideas that induct digital technologies, into India's healthcare, education, energy and retail sectors.
Rishabh Gulati, Managing Editor, NewsX; Poonam Khetrapal Singh, Regional Director for South-East Asia, World Health Organization (WHO); Pankaj R. Patel, Chairman, Zydus Cadila; Randeep Guleria, Director, All India Institute of Medical Sciences. The panel deliberates how in the race to develop a safe vaccine; developers are dealing with not just a global health emergency, but also a global economic and political emergency.